fax: 301-480-9488
Liver Failure and Liver Disease
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Article first published online: 24 MAY 2005
DOI: 10.1002/hep.20701
Copyright © 2005 American Association for the Study of Liver Diseases
Additional Information
How to Cite
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y.-C., Torbenson, M. S., Unalp-Arida, A., Yeh, M., McCullough, A. J. and Sanyal, A. J. (2005), Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology, 41: 1313–1321. doi: 10.1002/hep.20701
- †
Potential conflict of interest: Nothing to report.
- ‡
fax: 301-480-9488
A list of members of the Nonalcoholic Steatohepatitis Clinical Research Network is located in the Appendix.
Publication History
- Issue published online: 24 MAY 2005
- Article first published online: 24 MAY 2005
- Manuscript Accepted: 25 FEB 2005
- Manuscript Received: 12 NOV 2004
Funded by
- National Institute of Diabetes & Digestive & Kidney Diseases. Grant Numbers: 1U01DK061718, 1U01DK061728, 1U01DK061731, 1U01DK061732, 1U01DK061734, 1U01DK061737, 1U01DK061738, 5U01DK061730, 7U01DK061713, N01HR761019
- National Institute of Child Health and Human Development
References
- 1, , , , , , et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50: 1844–1850.
- 2, . Non-alcoholic steatohepatitis: Definitions and pathogenesis. J Gastroenterol Hepatol 2002; 17(Suppl 3): S377–S384.Direct Link:
- 3
- 4, , , , , , et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. HEPATOLOGY 2003; 37: 917–923.
- 5. Update on nonalcoholic fatty liver disease. J Clin Gastroenterol 2002; 34: 255–262.
- 6, , . Non-alcoholic fatty liver disease: an overview. J Gastroenterol Hepatol 2002; 17: 1136–1143.
- 7, , . The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003; 98: 960–967.Direct Link:
- 8. Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region? J Gastroenterol Hepatol 2003; 18: 124–138.
- 9, . Relation of elevated serum alanine aminotransferase activity with iron and antioxidant levels in the United States. Gastroenterology 2003; 124: 1821–1829.
- 10, , , . Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55: 434–438.
- 11, , , , , . Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. HEPATOLOGY 1999; 29: 664–669.
- 12, , , , , , et al. The histological features of pediatric nonalcoholic fatty liver disease (NAFLD) [Abstract]. HEPATOLOGY 2002; 36(Suppl): 412A.
- 13. Steatohepatitis in children. Best Pract Res Clin Gastroenterol 2002; 16: 749–765.
- 14. Nonalcoholic steatohepatitis. Semin Liver Dis 2004; 24: 3–20.
- 15, , , , , . Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413–1419.
- 16, , , , . Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 2467–2474.Direct Link:
- 17. Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond. HEPATOLOGY 2000; 31: 241–246.
- 18, , , , , , et al. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. HEPATOLOGY 2004; 39: 188–196.
- 19Nonalcoholic steatohepatitis clinical research network. HEPATOLOGY 2003; 35: 244.
- 20, . Intraclass correlations: Uses in assessing rater reliability. Psychol Bull 1979; 86: 420–428.
- 21, , . Analysis of Longitudinal Data. Oxford, England: Oxford University Press, 1995.
- 22, , , , , , et al. Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations. Mod Pathol 1998; 11: 560–565.
- 23, , , , , . Observer variation in assessment of liver biopsies of alcoholic patients. Alcohol Clin Exp Res 1988; 12: 173–178.
- 24, , , , . Idiopathic steatohepatitis in childhood: a multicenter retrospective study. J Pediatr 1995; 127: 700–704.
- 25, . Nonalcoholic steatohepatitis in children. J Pediatric Gastroenterol Nutr 2000; 30: 48–53.
- 26, , , , , , et al. Liver fibrosis in overweight patients. Gastroenterology 2000; 118: 1117–1123.
- 27, , , , . Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone. HEPATOLOGY 2003; 38: 1008–1017.

1527-3350/asset/olbannerleft.gif?v=1&s=4b2409f9534ed500d3c8da1940a23842e2b9932d)
1527-3350/asset/olbannerright.gif?v=1&s=141b9a8485298533c3e2016e937b0404f7d933e1)
1527-3350/asset/cover.gif?v=1&s=3cd983af6575c8dbfd6b47a63ffa95415ace15f8)